Clinical Trials Directory

Trials / Terminated

TerminatedNCT05166603

Expanding Access to Comprehensive Geriatrics Care Via Telehealth

Expanding Access to Comprehensive Geriatrics Care Via Telehealth (QUE 20-010)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
111 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

The overall objective of the TeleGRACE project is to improve the care and outcomes of older Veterans with a recent inpatient stay by expanding access to the evidence-based GRACE program, by evaluating a telehealth implementation.

Detailed description

The TeleGRACE evaluation will focus on three primary aims and a secondary aim: Primary Aim 1: To examine the effectiveness of the TeleGRACE program, the investigators designed a randomized controlled implementation trial (RCT) powered for the primary outcome of 90-day all-cause mortality. The investigators will also examine its effectiveness for the secondary outcomes including 90-day readmissions, 1-year ED utilization (VA and non-VA), 1-year all-cause readmissions, 1-year mortality, as well as patient, caregiver, and staff satisfaction. The investigators hypothesize that patients who receive TeleGRACE will have lower 90-day mortality than patients in usual care. Primary Aim 2: to examine the implementation of the TeleGRACE program. The implementation strategy is reflecting \& evaluating. Implementation outcomes are based on the REAIM framework and include reach, efficacy (Aim 1), and implementation (total number of Veterans served, fidelity). Primary Aim 3: to conduct a business-case analysis (BCA). The business case analysis will calculate the net financial savings or loss for TeleGRACE as the difference in the overall intervention costs and savings due to downstream benefits for patients receiving TeleGRACE versus usual care controls.

Conditions

Interventions

TypeNameDescription
OTHERTeleGRACEPatients receive a virtual home visit and care from the GRACE team

Timeline

Start date
2021-10-18
Primary completion
2022-04-29
Completion
2022-04-29
First posted
2021-12-22
Last updated
2024-01-22
Results posted
2023-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05166603. Inclusion in this directory is not an endorsement.